
Puma Biotechnology PBYI
€ 8.77
-7.66%
Puma Biotechnology ROE | PBYI
ROE Jährlich Puma Biotechnology
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.87 | 32.87 | 40.4 | 0.01 | 1190.76 | 1008.15 | -432.89 | -331.06 | -547.74 | -131.54 | -116.15 | -121.29 | -65.08 | -57.68 | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1190.76 | -547.74 | 35.19 |
ROE Vierteljährlich Puma Biotechnology
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.25 | 13.4 | 44.91 | 27.9 | 12.86 | 9.8 | 24.76 | 3.17 | 17.93 | 27.37 | 25.75 | 58.27 | 3.64 | -1.78 | 407.23 | 391.53 | 444.61 | 492.24 | 744.19 | 863.89 | 824.16 | 1008.15 | 692.06 | 66.67 | -90.58 | -432.89 | -458.23 | -402.93 | -317.86 | -331.06 | -361.81 | -465.21 | -482.0 | -547.74 | -462.15 | -348.7 | -234.42 | -131.54 | -126.87 | -124.85 | -124.52 | -116.15 | -126.76 | -128.06 | -129.84 | -121.29 | -99.71 | -134.16 | -166.06 | -214.23 | -212.24 | -204.84 | -197.43 | -190.03 | -191.85 | -153.0 | -114.14 | -56.46 | -18.82 | -18.82 | -18.82 |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1008.15 | -547.74 | -30.12 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Lyra Therapeutics
LYRA
|
269.84 | - | - | $ 24.9 M | ||
|
Brickell Biotech
BBI
|
-57.34 | - | -5.38 % | $ 6.06 M | ||
|
Applied Therapeutics
APLT
|
-185.29 | - | - | $ 8.42 M | ||
|
ESSA Pharma
EPIX
|
-22.91 | - | - | $ 8.86 M | ||
|
Generation Bio Co.
GBIO
|
-152.74 | - | - | $ 344 M | ||
|
Clearside Biomedical
CLSD
|
88.41 | - | - | $ 25.3 M | ||
|
Merus N.V.
MRUS
|
-33.23 | - | - | $ 5.78 B | ||
|
RAPT Therapeutics
RAPT
|
-68.38 | - | - | $ 2.36 B | ||
|
Annexon
ANNX
|
-97.66 | $ 4.0 | -7.62 % | $ 620 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
39.76 | $ 156.5 | -2.85 % | $ 20.5 B | ||
|
Amgen
AMGN
|
89.06 | $ 462.71 | -3.3 % | $ 249 B | ||
|
Theratechnologies
THTX
|
32.87 | - | - | $ 83.9 M | ||
|
Iovance Biotherapeutics
IOVA
|
-55.97 | $ 7.72 | -11.26 % | $ 2.76 M | ||
|
Biogen
BIIB
|
7.08 | $ 243.85 | -4.17 % | $ 35.7 B | ||
|
Ironwood Pharmaceuticals
IRWD
|
-9.17 | $ 4.03 | 6.9 % | $ 652 M | ||
|
Armata Pharmaceuticals
ARMP
|
79.51 | $ 3.01 | -4.14 % | $ 109 M | ||
|
Mustang Bio
MBIO
|
-20.16 | $ 0.39 | -5.63 % | $ 1.91 M | ||
|
MannKind Corporation
MNKD
|
-11.49 | $ 3.77 | -4.07 % | $ 1.15 B | ||
|
InflaRx N.V.
IFRX
|
-109.81 | $ 1.36 | -8.11 % | $ 91.5 M | ||
|
Immutep Limited
IMMP
|
-42.77 | $ 2.7 | -8.47 % | $ 3.93 B | ||
|
Insmed Incorporated
INSM
|
-172.78 | $ 108.79 | -1.1 % | $ 21.7 B | ||
|
Titan Pharmaceuticals
TTNP
|
-192.87 | - | -3.76 % | $ 3.47 M | ||
|
Jazz Pharmaceuticals plc
JAZZ
|
-8.25 | $ 227.25 | -3.16 % | $ 13.9 B | ||
|
BioLineRx Ltd.
BLRX
|
-8.68 | $ 1.77 | -4.95 % | $ 4.36 B | ||
|
Bristol-Myers Squibb Company
BMY
|
38.19 | $ 63.15 | -1.64 % | $ 128 B | ||
|
Johnson & Johnson
JNJ
|
32.87 | $ 272.47 | -1.4 % | $ 656 B | ||
|
Allena Pharmaceuticals
ALNA
|
-54.92 | - | 3.16 % | $ 1.9 M | ||
|
PainReform Ltd.
PRFX
|
-58.78 | $ 0.76 | -1.27 % | $ 492 K | ||
|
Kala Pharmaceuticals
KALA
|
-385.65 | $ 0.15 | -13.14 % | $ 1.22 M | ||
|
Prothena Corporation plc
PRTA
|
-87.03 | $ 7.9 | -5.84 % | $ 425 M | ||
|
TCR2 Therapeutics
TCRR
|
-107.78 | - | - | $ 58.1 M | ||
|
Dr. Reddy's Laboratories Limited
RDY
|
16.98 | $ 14.53 | -1.63 % | $ 12.1 B | ||
|
Keros Therapeutics
KROS
|
28.7 | $ 9.42 | -13.02 % | $ 351 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
-46.9 | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
Kazia Therapeutics Limited
KZIA
|
-169.83 | $ 7.13 | -11.76 % | $ 109 M | ||
|
TFF Pharmaceuticals
TFFP
|
-222.05 | - | -60.05 % | $ 125 K | ||
|
Sana Biotechnology
SANA
|
-151.77 | $ 2.32 | -9.38 % | $ 588 M | ||
|
Lineage Cell Therapeutics
LCTX
|
-142.61 | $ 0.98 | -4.85 % | $ 226 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
12.23 | $ 298.8 | -5.48 % | $ 5.78 B | ||
|
Longeveron
LGVN
|
-400.07 | $ 1.76 | -1.12 % | $ 30.9 B | ||
|
Eli Lilly and Company
LLY
|
77.78 | $ 1 366.97 | -3.62 % | $ 1.23 T | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-597.64 | - | -15.15 % | $ 60.3 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-15.82 | - | - | $ 521 M | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
-188.93 | $ 4.01 | -5.2 % | $ 48.9 M | ||
|
Axcella Health
AXLA
|
-1949.71 | - | -16.42 % | $ 249 M | ||
|
Compugen Ltd.
CGEN
|
34.4 | $ 1.94 | -4.68 % | $ 181 M |